Validations: Intended Use & Risk in Cloud (IaaS/PaaS/SaaS)
Supplier Audits: Paper, Remote, and On-Site Supplier Audits: Paper, Remote, and On-Site Supplier audits are critical components in the landscape of compliance within the pharmaceutical and biotechnology industries. These audits ensure that suppliers adhere to Good Manufacturing Practices (GMP), allowing for effective collaboration and risk management. As organizations increasingly leverage cloud services (IaaS, PaaS, SaaS), understanding the nuances of supplier…
Supplier Audits: Paper, Remote, and On-Site In the rapidly evolving landscape of the pharmaceutical industry, effective supplier audits are essential for ensuring compliance with various regulatory standards, notably US FDA, EMA, MHRA, and PIC/S guidelines. Auditing suppliers is not merely a best practice; it is a regulatory requirement that safeguards the integrity of pharmaceutical products through risk management and robust…
Cybersecurity Hooks: CIS/NIST and GxP Parallels Cybersecurity Hooks: CIS/NIST and GxP Parallels In the realm of pharmaceutical validation, understanding the interplay between cybersecurity standards, such as CIS (Center for Internet Security) and NIST (National Institute of Standards and Technology), and Good Automated Manufacturing Practice (GxP) requirements is essential for ensuring compliance and maintaining data integrity. This article provides a comprehensive…
Cybersecurity Hooks: CIS/NIST and GxP Parallels Cybersecurity Hooks: CIS/NIST and GxP Parallels Introduction to Cybersecurity in Pharmaceutical Validation The increasing reliance on cloud computing in the pharmaceutical industry necessitates a comprehensive understanding of the intersection between cybersecurity frameworks and Good Automated Manufacturing Practice (GxP) compliance. Recognizing the parallels between the CIS (Center for Internet Security) and NIST (National Institute of…
GxP vs Non-GxP Segregation in Multi-Tenant Tools GxP vs Non-GxP Segregation in Multi-Tenant Tools In today’s evolving pharmaceutical landscape, the use of cloud-based technologies has dramatically changed how companies approach data governance and software validation. As organizations transition to multi-tenant cloud environments, understanding the distinctions between Good Practice (GxP) and non-GxP systems becomes critical. This comprehensive guide aims to walk…
GxP vs Non-GxP Segregation in Multi-Tenant Tools GxP vs Non-GxP Segregation in Multi-Tenant Tools Introduction to GxP and Non-GxP Segregation in Multi-Tenant Tools In the rapidly evolving landscape of cloud computing, the distinction between Good Practice (GxP) and non-GxP environments within multi-tenant tools is crucial for pharmaceutical, clinical operations, and regulatory affairs professionals. This distinction ensures compliance with regulatory expectations…
Third-Party Integrations: API Risks and Evidence Third-Party Integrations: API Risks and Evidence In today’s rapidly evolving pharmaceutical landscape, the integration of third-party APIs into existing systems has become standard practice for enhancing functionalities and achieving operational efficiencies. However, these integrations also introduce distinct risks that can impact compliance with cGMP regulations and guidelines from regulatory bodies such as the US…
Proof of Intended Use: Scenarios, Records, and Logs Proof of Intended Use: Scenarios, Records, and Logs The validation of computer systems, particularly within the framework of cloud technology in the pharmaceutical sector, involves numerous considerations, primarily the proof of intended use. This document outlines a step-by-step tutorial on managing the compliance and governance aspects of Computer Software Assurance (CSA) and…
Rapid Releases in SaaS: Validation Strategies Rapid Releases in SaaS: Validation Strategies The advent of cloud computing has revolutionized the way pharmaceutical companies manage their data and software applications. As organizations increasingly adopt Software as a Service (SaaS) solutions, rigorous validation practices become crucial to ensure compliance with regulatory requirements such as US FDA 21 CFR Part 11, EMA, MHRA,…
Operational Qualifications in Cloud: What’s Practical In the evolving landscape of pharmaceutical validation, organizations are increasingly leveraging cloud technologies. Ensuring compliance with regulatory standards such as those enforced by the FDA, EMA, MHRA, and PIC/S while employing cloud solutions is crucial for sustaining operational effectiveness and ensuring data integrity. This article provides a step-by-step tutorial on operational qualifications in the…